Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.500
+0.030 (1.21%)
At close: Mar 25, 2026, 4:00 PM EDT
2.550
+0.050 (2.00%)
After-hours: Mar 25, 2026, 7:52 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $417.72 million as of March 25, 2026. Its market cap has increased by 80.34% in one year.
Market Cap
417.72M
Enterprise Value
266.28M
1-Year Change
80.34%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $417.72M, a decrease of -83.83%. That is a compound annual growth rate of -51.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 423.15M | 39.11% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 435.73M |
| Atea Pharmaceuticals | 433.42M |
| Aclaris Therapeutics | 432.94M |
| REGENXBIO | 428.39M |
| Lexeo Therapeutics | 424.06M |
| Eupraxia Pharmaceuticals | 423.55M |
| Vanda Pharmaceuticals | 422.03M |
| Aura Biosciences | 417.85M |